Tumor-responsive cytochrome c nanocapsules trigger pyroptosis and boost anti-PD-1 immunotherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Inflammasome and immune disorders · Cancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Global trends and forecasts of breast cancer incidence and deaths10.1038/s41597-023-02253-5 ↗
2. Antibody-drug conjugates in breast cancer: overcoming resistance and boosting immune response10.1172/JCI172156 ↗
3. Targeted therapy and mechanisms of drug resistance in breast cancer10.3390/cancers15041320 ↗
4. The foundations of immune checkpoint blockade and the ipilimumab approval decennial10.1038/s41573-021-00345-8 ↗
5. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade10.1016/j.cell.2021.09.020 ↗
6. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends10.1038/s41392-023-01522-4 ↗
7. A guide to cancer immunotherapy: from T cell basic science to clinical practice10.1038/s41577-020-0306-5 ↗
8. Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity10.1016/j.ccell.2023.04.016 ↗
9. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion10.1038/s41568-021-00339-z ↗
10. Role of tumor microenvironment in cancer progression and therapeutic strategy10.1002/cam4.5698 ↗
11. Nanoparticles destabilizing the cell membranes triggered by NIR light for cancer imaging and photo-immunotherapy10.1038/s41467-024-50020-w ↗
12. Activating CD8+ T Cells by Pt(IV) prodrug-based nanomedicine and aPD-L1 antibody for enhanced cancer immunotherapy10.1002/adma.202311640 ↗
13. Hot and cold tumors: immunological features and the therapeutic strategies10.1002/mco2.343 ↗
14. Immunogenic cell death inducing metal complexes for cancer therapy10.1002/anie.202300662 ↗
15. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity10.1038/s41568-024-00674-x ↗
16. Cobalt(III) prodrug-based nanomedicine for inducing immunogenic cell death and enhancing chemo-immunotherapy10.1016/j.jconrel.2024.07.042 ↗
17. Pyroptosis: mechanisms and diseases10.1038/s41392-021-00507-5 ↗
18. A pyroptosis nanotuner for cancer therapy10.1038/s41565-022-01125-0 ↗
19. Gasdermin E in glioblastoma-pyroptosis resistance and tumor-promoting functions10.1038/s41420-025-02572-z ↗
20. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy10.1038/s41392-022-01046-3 ↗
21. Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis10.1097/BS9.0000000000000117 ↗
22. STING contributes to lipopolysaccharide-induced tubular cell inflammation and pyroptosis by activating endoplasmic reticulum stress in acute kidney injury10.1038/s41419-024-06600-1 ↗
23. Pyroptosis and pyroptosis-inducing cancer drugs10.1038/s41401-022-00887-6 ↗
24. Pyroptosis-inducing biomaterials pave the way for transformative antitumor immunotherapy10.1002/advs.202410336 ↗
25. Simultaneous activation of pyroptosis and cGAS-STING pathway with epigenetic/ photodynamic nanotheranostic for enhanced tumor photoimmunotherapy
26. Biomineralized two-enzyme nanoparticles regulate tumor glycometabolism inducing tumor cell pyroptosis and robust antitumor immunotherapy10.1002/adma.202206851 ↗
27. Diverse functions of cytochrome c in cell death and disease10.1038/s41418-024-01284-8 ↗
28. Cytochrome c in cancer therapy and prognosis10.1042/BSR20222171 ↗
29. Targeting hypoxic tumor plasticity for recapturing photodynamic-immunotherapy sensitivity via fluorinated polysensitizers10.1002/adfm.202310450 ↗
30. BCL-2 family proteins: changing partners in the dance towards death10.1038/cdd.2017.186 ↗
31. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation10.1038/s41467-019-09397-2 ↗
32. A bioorthogonal system reveals antitumour immune function of pyroptosis10.1038/s41586-020-2079-1 ↗
33. Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy10.1126/scitranslmed.add2712 ↗
34. A pH-responsive detachable PEG shielding strategy for gene delivery system in cancer therapy10.1021/acs.biomac.7b00080 ↗
35. The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer10.1038/s41420-020-00349-0 ↗
36. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis10.1186/s13045-024-01545-6 ↗
37. Trade-off effect of polymeric nano-medicine in anti-cancer drug delivery10.1016/j.giant.2021.100074 ↗
38. Harnessing innate immune pathways for therapeutic advancement in cancer10.1038/s41392-024-01765-9 ↗
39. Dai · Adv. Funct. Mater. · 2018 · 2810.1002/adfm.201707249 ↗